Cargando…

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD

BACKGROUND: Serum procalcitonin (PCT) and C-reactive protein (CRP) are markers of systemic inflammation and bacterial infection. We aimed to compare the usefulness of procalcitonin and CRP in patients with community-acquired pneumonia and exacerbations of chronic obstructive pulmonary disease (COPD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Çolak, Ayfer, Yılmaz, Celalettin, Toprak, Burak, Aktoğu, Serir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Medical Biochemists of Serbia 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471644/ https://www.ncbi.nlm.nih.gov/pubmed/28680355 http://dx.doi.org/10.1515/jomb-2017-0011

Ejemplares similares

Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD
por: Hsu, Chin-Wang, et al.
Publicado: (2022)

The role of serum procalcitonin and CRP levels in determining of etiology and outcome in acute exacerbations of COPD
por: Ceylan, O, et al.
Publicado: (2015)

Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD
por: Bafadhel, Mona, et al.
Publicado: (2011)

The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
por: Nikzad, Mahsa, et al.
Publicado: (2021)

Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients
por: Mou, Shan, et al.
Publicado: (2022)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022)

1336. Impact of Procalcitonin-Guided Antibiotic Management in Chronic Obstructive Pulmonary Disease Exacerbation and Community-Acquired Pneumonia
por: Triner, Molly, et al.
Publicado: (2019)

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
por: Andrijevic, Ilija, et al.
Publicado: (2014)

Effect of sample type, centrifugation and storage conditions on vitamin D concentration
por: Colak, Ayfer, et al.
Publicado: (2013)

Community-Acquired Respiratory Complications in the Intensive Care Unit: Pneumonia and Acute Exacerbations of COPD
por: Restrepo, M. I., et al.
Publicado: (2010)

Diagnostic yield of EBUS-TBNA for lymphoma and review of the literature
por: Erer, Onur Fevzi, et al.
Publicado: (2017)

Contribution of cell block obtained by endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of malignant diseases and sarcoidosis
por: Erer, Onur Fevzi, et al.
Publicado: (2017)

S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever
por: Taylan, Ali, et al.
Publicado: (2015)

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

Biomarkers in Pneumonia—Beyond Procalcitonin
por: Karakioulaki, Meropi, et al.
Publicado: (2019)

First Observation of Hemoglobin Jabalpur [Beta 3 (NA3) Leu>Pro] in the Turkish Population
por: Çolak, Ayfer, et al.
Publicado: (2014)

Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after abdominal surgery
por: Abu Elyazed, Mohamed M, et al.
Publicado: (2017)

Comparison between presepsin, procalcitonin, and CRP as biomarkers to diagnose sepsis in critically ill patients
por: Juneja, Deven, et al.
Publicado: (2023)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Can we recognize severe community-acquired pneumonia without pneumonia severity index? Use of modified qSOFA with procalcitonin
por: Güleç, Tolgahan, et al.
Publicado: (2023)

Serum Procalcitonin Level as a Predictor of Bacterial Infection in Patients with COPD Exacerbation
por: Abedini, Atefeh, et al.
Publicado: (2019)

Impaired Hemorheology in Exacerbations of COPD
por: Ugurlu, Erhan, et al.
Publicado: (2017)

Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acquired pneumonia
por: Wang, Wenlong, et al.
Publicado: (2020)

Usefulness of Plasma Procalcitonin to Predict Severity in Elderly Patients with Community-Acquired Pneumonia
por: Kim, Ji Hye, et al.
Publicado: (2013)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units
por: Lu, Zhiwei, et al.
Publicado: (2016)

Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units
por: Takir, Huriye Berk, et al.
Publicado: (2017)

Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study
por: Daubin, Cédric, et al.
Publicado: (2008)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

The Diagnostic Value of D-dimer, Procalcitonin and CRP in Acute Appendicitis
por: Kaya, Bulent, et al.
Publicado: (2012)

Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia
por: Cohen, Jérémie F., et al.
Publicado: (2012)

Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia
por: Stockmann, Chris, et al.
Publicado: (2018)

Transcriptional analysis identifies potential biomarkers and molecular regulators in pneumonia and COPD exacerbation
por: Bertrams, Wilhelm, et al.
Publicado: (2020)

Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study
por: Jung, Anna Lena, et al.
Publicado: (2023)

Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD
por: Corti, Caspar, et al.
Publicado: (2016)

Lower long-term mortality in obese patients with community-acquired pneumonia: possible role of CRP
por: Chen, Jin, et al.
Publicado: (2019)

Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria
por: Kasperska-Zajac, A., et al.
Publicado: (2012)

Pneumonia in exacerbations of COPD: what is the clinical significance?
por: Trethewey, Samuel P., et al.
Publicado: (2020)

Eosinopenia Predicting Long-term Mortality in Hospitalized Acute Exacerbation of COPD Patients with Community-acquired Pneumonia—A Retrospective Analysis
por: Mao, Yanxiong, et al.
Publicado: (2021)

Correlation between plasma peroxides and procalcitonin levels in patients with severe streptococcal community acquired pneumonia
por: Borrelli, E, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_f0jf9u6flvete1vnqokeh3n69v